Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Henlius Biotech, Inc. has announced a board meeting scheduled for August 26, 2024, to discuss and approve its interim results for the first half of the year ending June 30, 2024, and to consider the declaration of an interim dividend. The meeting will address other business matters as well. This event could indicate upcoming financial developments for the company and its shareholders.
For further insights into HK:2696 stock, check out TipRanks’ Stock Analysis page.